PriMera Scientific Surgical Research and Practice (ISSN: 2836-0028)

Review Article

Volume 2 Issue 2

An Overview on Microspheres and Microcapsules as Promising Drug Carriers

Swarnima Pandey* and Geeta Biswas

July 03, 2023

DOI : 10.56831/PSSRP-02-047

View PDF

Abstract

     Microspheres are tiny sphere-shaped particles with sizes under 200 nm. The analysis focuses on the microspheres of its qualities, forms, preparation, outcomes, and application of process variables. This article discusses a cutting-edge drug delivery technology.

     It overcame a number of issues with other dosing forms. The various kinds of microspheres are employed in a variety of ways to increase therapeutic efficacy and bioavailability. Investigations are being done into how process factors affect drug release, drug trapping, and particle size. Microspheres are typically free-flowing powders made of synthetic polymers that are naturally biodegradable. A medication is located in the centre of a microsphere, where it is protected by a unique polymeric membrane.

keywords: Microspheres; Drug Delivery; Particle Size; Controlled Release

References

  1. Garg S and Sharma S. “Gastroretentive drug delivery systems”. Drug Deliv. Oral (2003): 160-166.
  2. Ansel HC, Allen LV and Popouich NG. “Pharmaceutical Dosage Forms and Drug Delivery Systems”. 7th ed. Lippincott, Philadelphia (2000): 229-234.
  3. Macheras P, Reppas C and Dressman JB. “Biopharmaceutics of Orally Administered Drugs”. Ellis Horwood Series in Pharm. Tech., Ellis Horwood Limited, New York (1995): 74.
  4. Vyas SP and Khar RK. “Targeted and Controlled Drug Delivery”. 2nd ed. CBS Publishers and Distributors, New Delhi, India (2002): 417.
  5. Li HK, Robinson JR and Lee VHL. “Influence of drug properties and routes of drug administration on the design of sustained and controlled release systems”. In: Robinson, J.R., Lee, V.H.L. (Ed.), Controlled Drug Delivery Fundamentals and Applications, 2nd ed. Marcel Dekker, New York.
  6. Lordi NG. “Sustained release dosage forms”. In: Lachman, L., Lieberman, H.A., Kanig, J.L. (Ed.), The Theory and Practice of Industrial Pharmacy, 3rd ed. Varghese Publishing House, Bombay (1991): 430-431.
  7. The Biopharmaceutics Classification System (BCS) Guidance, Center for Drug Evaluation and Research (CDER), USFDA.
  8. Benoit JP., et al. “Biodegradabla microspheres: advances in production technology. In: Benita, S. (Ed.), Microencapsulation Methods and Industrial Applications”. Marcel Dekker, New York (1996): 35-72.
  9. Bhalerao SS, Lalla JK and Rane MS. “Study of processing parameters influencing the properties of diltiazem hydrochloride microspheres”. J. Microencapsul 18 (2011): 299-307.
  10. Kilicarslan M and Baykara T. “Effects of the permeability characteristics of different polymethacrylates on the pharmaceutical characteristics of verapamil hyhdrochloride-loaded microspheres”. J. Microencapsul 21 (2004): 175-189.
  11. Kilicarslan M and Baykara T. “The effect of drug/polymer ratio on the properties of the Verapamil HCl loaded microspheres”. Int. J. Pharm 252 (2013): 99-109.
  12. Soppimath KS, Kulkarni AR and Aminabhavi TM. “Encapsulation of antihypertensive drugs in cellulose-based matrix microspheres: characterization and release kinetics of microspheres and tableted microspheres”. J. Microencapsul 18 (2011): 397-409.
  13. Obeidat WM and Price JC. “Preparation and evaluation of Eudragit S 100 microspheres as pH-sensitive preparations for piroxicam and theophylline using the emulsion-solvent evaporation method”. J. Microencapsul 23 (2016): 195-202.
  14. Sengel CT, Hascicek C and Gonul N. “Development and in-vitro evaluation of modified release tablets including ethylcellulose microspheres loaded with diltiazem hydrochloride”. J. Microencapsul 23 (2006): 135-152.
  15. Kim BK, Hwang SJ and Park JB. “Preparation and characterization of drug-loaded polymethacrylate microspheres by an emulsion solvent evaporation method”. J. Microencapsul 19 (2012): 811-822.
  16. Freitas S, Merkle HP and Gander B. “Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology”. J. Control. Release 102 (2015): 313-332.
  17. Soppimath KS and Aminabhavi TM. “Ethyl acetate as a dispersing solvent in the production of poly(DL-lactide-co-glycolide) microspheres: effect of process parameters and polymer type”. J. Microencapsul 19 (2002): 281-292.
  18. Horoz BB., et al. “Effect of different dispersing agents on the characteristics of Eudragit microspheres prepared by a solvent evaporation method”. J. Microencapsul 21 (2014): 191-202.
  19. Mateovic T., et al. “The influence of stirring rate on biopharmaceutical properties of Eudragit RS microspheres”. J. Microencapsul 19 (2012): 29-36.
  20. Moussa IS and Cartilier LH. “Evaluation of cross-linked amylose press- coated tablets for sustained drug delivery”. Int. J. Pharm 149 (1997): 139-149.
  21. Kristmundsdottir T, Gudmundsson OS and Ingvarsdottir K. “Release of diltiazem from Eudragit microparticles prepared by spray-drying”. Int. J. Pharm 137 (1996): 159-165.
  22. Sood A and Panchagnula R. “Drug release evaluation of diltiazem CR preparations”. Int. J. Pharm 175 (1998): 95-107.
  23. Bonferoni MC., et al. “Characterization of a diltiazem-lambda carrageenan complex”. Int. J. Pharm 200 (2010): 207-216.
  24. Toti US and Aminabhavi TM. “Modified guar gum matrix tablet for controlled release of diltiazem hydrochloride”. J. Control. Release 95 (2014): 567-577.
  25. Follonier N, Doelker E and Cole ET. “Various ways of modulating the release of diltiazem hydrochloride from hot-melt extruded sustained release pellets prepared using polymeric materials”. J. Control. Release 36 (1995): 243-250.
  26. Wilding IR., et al. “Pharmacoscintigraphic evaluation of a modified release (Geomatrix ®) diltiazem formulation”. J. Control. Release 33 (1995): 89-97.
  27. Fukui E, Uemura K and Kobayashi M. “Studies on applicability of press- coated tablets using hydroxypropylcellulose (HPC) in the outer shell for timed- release preparations”. J. Control. Release 68 (2010): 215-223.
  28. Kamel HE, Gohary OMNA and Hosny EA. “Alginate-diltiazem hydrochloride beads: optimization of formulation factors, in vitro and in vivo availability”. J. Microencapsul 20 (2013): 211-225.
  29. Halder A, Mukherjee S and Sa B. “Development and evaluation of polyethyleneimine - treated calcium alginate beads for sustained release of diltiazem”. J. Microencapsul 22 (2015): 67-80.